Back to SNDX
KINGDON CAPITAL MANAGEMENT, L.L.C. → SNDX
KINGDON CAPITAL MANAGEMENT, L.L.C. SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$54.6M
Q2 2026
Peak value
$58.4M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $16.1M |
| Q4 2023 | $16.1M |
| Q1 2024 | $21.3M |
| Q2 2024 | $18.4M |
| Q3 2024 | $19.3M |
| Q4 2024 | $26.4M |
| Q1 2025 | $24.6M |
| Q2 2025 | $19.7M |
| Q3 2025 | $38.5M |
| Q4 2025 | $49.4M |
| Q1 2026 | $58.4M |
| Q2 2026 | $54.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $54.6M | 2.50M | — | — |
| Q1 2026 | $58.4M | 2.50M | — | — |
| Q4 2025 | $49.4M | 2.35M | — | — |
| Q3 2025 | $38.5M | 2.50M | — | — |
| Q2 2025 | $19.7M | 2.10M | — | — |
| Q1 2025 | $24.6M | 2.00M | — | — |
| Q4 2024 | $26.4M | 2.00M | — | — |
| Q3 2024 | $19.3M | 1.00M | — | — |
| Q2 2024 | $18.4M | 895.0K | — | — |
| Q1 2024 | $21.3M | 895.0K | — | — |
| Q4 2023 | $16.1M | 746.3K | — | — |
| Q4 2023 | $16.1M | 746.3K | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M